Hepatitis B at Birth: Timing the Vaccine and Immunoglobulin
A 28-year-old woman is HBsAg-positive and HBeAg-positive, with HBV DNA 2 × 10^8 IU/mL. She delivers a male infant at 38 weeks by normal vaginal delivery. The hospital's vaccine refrigerator was at 12°C for 6 hours overnight and has been back at 4°C for 3 hours; the hepatitis B vaccine vials were in that refrigerator. The nurse asks whether the birth-dose vaccine is still usable and whether immunoglobulin is needed. The infant weighs 3.1 kg and is stable. The mother received no antiviral therapy during pregnancy. The hospital has hepatitis B immunoglobulin (HBIG) available but no HBIG for a second dose. The national schedule gives HBV vaccine at birth, 6, 10, and 14 weeks. The mother plans to breastfeed. She has no other markers of liver disease.
1. Decide whether the vaccine vials are usable. Explain the cold-chain principle and what you would do.
Read the worked answer
The refrigerator was at 12°C for 6 hours, above the recommended 2–8°C range. Hepatitis B vaccine is adjuvanted and can lose potency after heat exposure, and the deviation was not monitored with a validated indicator. The safe decision is not to use those vials for the birth dose; obtain new vaccine from a valid cold chain. Because the birth dose is time-critical, do not wait until morning. Give HBIG immediately, within 12 hours if possible, and administer a new HBV vaccine within 24 hours at a separate site. If no valid vaccine can be obtained within 24 hours, give HBIG and start the vaccine as soon as possible; the first dose should not be delayed by the cold-chain problem. Document the breach and report it.
2. Explain why this infant needs HBIG in addition to vaccine, and state the timing. Does the high maternal viral load change anything?
Read the worked answer
The infant needs HBIG because the mother is HBeAg-positive with a very high HBV DNA (2 × 10^8 IU/mL), which means high infectivity. Vaccine alone takes weeks to produce protective anti-HBs, and the infant may be infected at delivery. HBIG provides preformed antibody that neutralizes virus in the birth canal and bloodstream during the gap. Give HBIG within 12 hours, ideally, and the first vaccine dose within 24 hours, at different sites. The high viral load increases the risk of failure of immunoprophylaxis, but it does not change the immediate plan; it strengthens the need for both. Antiviral therapy in the mother would have been considered earlier in pregnancy, but it is too late now. Breastfeeding can continue because prophylaxis is given.
3. At 9 months, what test would you do to determine whether the infant is infected or protected? Explain the interpretation.
Read the worked answer
At 9 months, test HBsAg and anti-HBs. If HBsAg is negative and anti-HBs is above 10 mIU/mL, the infant is protected and the schedule can be completed. If HBsAg is positive, the infant is infected and needs referral for monitoring, even if anti-HBs is present. If HBsAg is negative but anti-HBs is below 10 mIU/mL, give an additional vaccine dose and retest. Testing earlier than 9 months is unreliable because HBIG and maternal antibody can be detected and may confuse the result. Anti-HBc IgM is not the primary screening test in infants. The high maternal viral load means the child should be followed carefully even if the birth prophylaxis was timely.